Wyeth Rapamune Off-Label Marketing Settlement Will Not Alter Pfizer’s CIA
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer subsidiary to pay $490.9 million to resolve criminal and civil liability for marketing its immunosuppressive for unapproved uses; actions predate Pfizer’s 2009 corporate integrity agreement.